Home/Filings/4/0001179110-10-013213
4//SEC Filing

Brugger Stephen B 4

Accession 0001179110-10-013213

CIK 0001235010other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 11:34 AM ET

Size

5.5 KB

Accession

0001179110-10-013213

Insider Transaction Report

Form 4
Period: 2010-08-24
Brugger Stephen B
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2010-08-24$15.22/sh134$2,039209,645 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
  • [F2]This transaction was executed in multiple trades at prices ranging from $14.94 to $15.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeother

Related Parties

1
  • filerCIK 0001294347

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 11:34 AM ET
Size
5.5 KB